Koers Isodiol International Inc Other OTC
Aandelen
CA46500L1013
Farmaceutische producten
Omzet 2018 | 19,14 mln. 17,65 mln. | Omzet 2019 | 22,25 mln. 20,51 mln. | Marktkapitalisatie | 49,96 mln. 46,06 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | -36 mln. -33,2 mln. | Nettowinst (verlies) 2019 | -126 mln. -116 mln. | EV/omzet 2018 | 12,6 x |
Nettoliquiditeiten 2018 | 15,55 mln. 14,34 mln. | Nettoschuld 2019 | 5,22 mln. 4,82 mln. | EV/omzet 2019 | 2,48 x |
K/w-verhouding 2018 |
-4,94
x | K/w-verhouding 2019 |
-0,37
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24-05-17 |
Director/Board Member | - | 30-08-18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14-02-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24-05-17 |
Director/Board Member | - | 30-08-18 | |
Director/Board Member | - | 21-11-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,29% | 6,09 mld. | |
-21,28% | 4,14 mld. | |
+4,52% | 3,23 mld. | |
-18,16% | 2,83 mld. | |
-7,70% | 2,39 mld. | |
+41,50% | 1,9 mld. | |
-4,05% | 1,57 mld. | |
-15,56% | 1,55 mld. | |
-14,62% | 1,5 mld. |